The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Serum levels of IL-6, IL-10 and TNF-α in patients with bipolar disorder and schizophrenia: differences in pro- and anti-inflammatory balance
Open accessAbstract
OBJECTIVE: Previous reports suggest that cytokines act as potential mediators of the interaction between the immune and neuroendocrine systems, and that a proinflammatory state may be associated with bipolar disorder and schizophrenia. The aim is to compare cytokine levels in both disorders. METHOD: Twenty euthymic bipolar disorder patients, 53 chronic stabilized schizophrenia patients and 80 healthy controls were recruited. Subjects were all non-smokers and non-obese. Cytokines TNF-α, IL-6, and IL-10 were examined by sandwich ELISA. RESULTS: IL-6 levels were increased in schizophrenia patients when compared to controls (p < 0.0001) and euthymic bipolar disorder patients (p < 0.0001). IL-6 levels were no different in controls compared to euthymic bipolar disorder patients (p = 0.357). IL-10 was lower in controls compared to schizophrenia patients (p = 0.001) or to bipolar disorder patients (p = 0.004). There was no significant difference in TNF-α serum levels among the groups (p = 0.284). Gender-based classification did not significantly alter these findings, and no correlation was found between the antipsychotic dose administered and cytokine levels in patients with schizophrenia. DISCUSSION: These findings evidence a chronic immune activation in schizophrenia. Bipolar disorder seems to present an episode-related inflammatory syndrome. Increased anti-inflammatory factor IL-10 in bipolar disorder and schizophrenia suggests different patterns of inflammatory balance between these two disorders. Results further support the need to investigate cytokines as possible biomarkers of disease activity or treatment response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Rating Scale for Mania: Reliability, Validity and Sensitivity
Young, R. C., Biggs, J. T., Ziegler, V. E., & Meyer, D. A. (1978) · British Journal of Psychiatry · doi:10.1192/bjp.133.5.429 · Cited by 8,744
Cytokines sing the blues: inflammation and the pathogenesis of depression
Raison, C. L., Capuron, L., & Miller, A. H. (2006) · Trends in Immunology · doi:10.1016/j.it.2005.11.006 · Cited by 3,009
Genes for Schizophrenia and Bipolar Disorder? Implications for Psychiatric Nosology
Craddock, N. (2005) · Schizophrenia Bulletin · doi:10.1093/schbul/sbj033 · Cited by 496
Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder
Brietzke, E., Stertz, L., Fernandes, B. S., Kauer-Sant’Anna, M., Mascarenhas, M., Escosteguy Vargas, A., Chies, J. A., & Kapczinski, F. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.12.001 · Cited by 423
Self-citationLicinio, J., & Wong, M.-L. (1999) · Molecular Psychiatry · doi:10.1038/sj.mp.4000586 · Cited by 380 · cited 1×
“Over the years, a significant body of accumulated evidence suggests that major depression is associated with dysfunction of inflammatory mediators.(15) Patients with unipolar depression who are otherwise clinically healthy have been shown to present activated inflammatory pathways, with increased pro-inflammatory cyto…”
BackgroundPremature Mortality From General Medical Illnesses Among Persons With Bipolar Disorder: A Review
Roshanaei-Moghaddam, B., & Katon, W. (2009) · Psychiatric Services · doi:10.1176/ps.2009.60.2.147 · Cited by 305
Regulation of the HPA axis by cytokines.
Turnbull, A. V., & Rivier, C. (1995) · Brain, Behavior, and Immunity · doi:10.1006/brbi.1995.1026 · Cited by 289
TNF-α as a molecular target in bipolar disorder
Brietzke, E., & Kapczinski, F. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.01.006 · Cited by 163
Self-citationA systemic toxicity index developed to assess peripheral changes in mood episodes
Kapczinski, F., Dal-Pizzol, F., Teixeira, A. L., Magalhaes, P. V. S., Kauer-Sant'Anna, M., Klamt, F., de Bittencourt Pasquali, M. A., Quevedo, J., Gama, C. S., & Post, R. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.112 · Cited by 117
Self-citation
Research works printed but not linked: 30
- Berrettini WH, 2000, Are schizophrenic and bipolar disorders related?: A review of family and molecular studies, Biol Psychiatry., 48, 531, 10.1016/S0006-3223(00)00883-0 · DOI · Paper page
- Andreazza AC, 2008, Oxidative stress markers in bipolar disorder: a meta-analysis, J Affect Disord., 111, 135, 10.1016/j.jad.2008.04.013 · DOI · Paper page
- Gama CS, 2006, Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in schizophrenia: a study of patients treated with haloperidol or clozapine, Prog Neuropsychopharmacol Biol Psychiatry., 30, 512, 10.1016/j.pnpbp.2005.11.009 · DOI
- Gama CS, 2008, Elevated serum thiobarbituric acid reactive substances in clinically symptomatic schizophrenic males, Neurosci Lett., 433, 270, 10.1016/j.neulet.2008.01.018 · DOI
- Vargas HE, 2008, Decreased serum neurotrophin 3 in chronically medicated schizophrenic males, Neurosci Lett., 440, 197, 10.1016/j.neulet.2008.04.027 · DOI
- Gama CS, 2007, Serum levels of brain-derived neurotrophic factor in patients with schizophrenia and bipolar disorder, Neurosci Lett., 420, 45, 10.1016/j.neulet.2007.04.001 · DOI
- Kunz M, 2008, Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in different phases of bipolar disorder and in schizophrenia, Prog Neuropsychopharmacol Biol Psychiatry., 32, 1677, 10.1016/j.pnpbp.2008.07.001 · DOI · Paper page
- Elkis H, 2008, Brazilian Consensus on second-generation antipsychotics and metabolic disorders, Rev Bras Psiquiatr., 30, 77
- Guimaraes LR, 2008, Serum levels of brain-derived neurotrophic factor in schizophrenia on a hypocaloric diet, Prog Neuropsychopharmacol Biol Psychiatry., 32, 1595, 10.1016/j.pnpbp.2008.06.004 · DOI
- Leitao-Azevedo CL, 2006, Increased dyslipidemia in schizophrenic outpatients using new generation antipsychotics, Rev Bras Psiquiatr., 28, 301, 10.1590/S1516-44462006005000016 · DOI
- Kim YK, 2007, Cytokine imbalance in the pathophysiology of major depressive disorder, Prog Neuropsychopharmacol Biol Psychiatry., 31, 1044, 10.1016/j.pnpbp.2007.03.004 · DOI · Paper page
- Yang K, 2007, Levels of serum interleukin (IL)-6, IL-1beta, tumour necrosis factor-alpha and leptin and their correlation in depression, Aust N Z J Psychiatry., 41, 266, 10.1080/00048670601057759 · DOI
- Goldstein BI, 2009, Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature, J Clin Psychiatry., 70, 1078, 10.4088/JCP.08r04505 · DOI · Paper page
- Brietzke E, 2009, Abnormalities in serum chemokine levels in euthymic patients with bipolar disorder, Brain Behav Immun., 23, 1079, 10.1016/j.bbi.2009.04.008 · DOI
- Potvin S, 2008, Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review, Biol Psychiatry., 63, 801, 10.1016/j.biopsych.2007.09.024 · DOI · Paper page
- Kapczinski F, 2009, The potential use of biomarkers as an adjunctive tool for staging bipolar disorder, Prog Neuropsychopharmacol Biol Psychiatry., 33, 1366, 10.1016/j.pnpbp.2009.07.027 · DOI · Paper page
- Rothermundt M, 2001, Review of immunological and immunopathological findings in schizophrenia, Brain Behav Immun., 15, 319, 10.1006/brbi.2001.0648 · DOI · Paper page
- Strous RD, 2006, Schizophrenia, autoimmunity and immune system dysregulation: a comprehensive model updated and revisited, J Autoimmun., 27, 71, 10.1016/j.jaut.2006.07.006 · DOI · Paper page
- Romano F, 1996, Tradução e adaptação de um instrumento de avaliação psicopatológica das psicoses: a escala breve de avaliação psiquiátrica. Versão Ancorada (BPRS-A), J Bras Psiquiatr., 45, 43
- Lima MS, 2007, The Portuguese version of the Clinical Global Impression-Schizophrenia Scale: validation study, Rev Bras Psiquiatr., 29, 246, 10.1590/S1516-44462007000300010 · DOI
- Hamilton M, 1960, A rating scale for depression, J Neurol Neurosurg Psychiatry., 23, 56, 10.1136/jnnp.23.1.56 · DOI · Paper page
- Naudin J, 1996, Elevated circulating levels of IL-6 in schizophrenia, Schizophr Res., 20, 269, 10.1016/0920-9964(96)00014-X · DOI
- Ganguli R, 1994, Serum interleukin-6 concentration in schizophrenia: elevation associated with duration of illness, Psychiatry Res., 51, 1, 10.1016/0165-1781(94)90042-6 · DOI · Paper page
- Erbagci AB, 2001, Serum IL-1beta, sIL-2R, IL-6, IL-8 and TNF-alpha in schizophrenic patients, relation with symptomatology and responsiveness to risperidone treatment, Mediators Inflamm., 10, 109, 10.1080/09629350123895 · DOI
- Kauer-Sant'Anna M, 2009, Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs: late-stage bipolar disorder, Int J Neuropsychopharmacol., 12, 447, 10.1017/S1461145708009310 · DOI · Paper page
- Gama CS, 2008, Serum levels of brain-derived neurotrophic factor and thiobarbituric acid reactive substances in chronically medicated schizophrenic patients: a positive correlation, Rev Bras Psiquiatr., 30, 337, 10.1590/S1516-44462008000400006 · DOI
- Kapczinski F, 2008, Increased oxidative stress as a mechanism for decreased BDNF levels in acute manic episodes, Rev Bras Psiquiatr., 30, 243, 10.1590/S1516-44462008000300011 · DOI
- Jacka FN, 2008, Brain-derived neurotrophic factor: a modifiable common mediator in both the pathophysiology of psychiatric illness and in successful pharmacological treatments, Acta Neuropsychiatrica., 20, 223, 10.1111/j.1601-5215.2008.00323.x · DOI
- Molteni R, 2002, A high-fat, refined sugar diet reduces hippocampal brain-derived neurotrophic factor, neuronal plasticity, and learning, Neuroscience., 112, 803, 10.1016/S0306-4522(02)00123-9 · DOI · Paper page
- Drzyzga L, 2006, Cytokines in schizophrenia and the effects of antipsychotic drugs, Brain Behav Immun., 20, 532, 10.1016/j.bbi.2006.02.002 · DOI · Paper page
Cited by
From gut dysbiosis to altered brain function and mental illness: mechanisms and pathways
Rogers, G. B., Keating, D. J., Young, R. L., Wong, M.-L., Licinio, J., & Wesselingh, S. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.50 · Cited by 969
Fillman, S. G., Cloonan, N., Catts, V. S., Miller, L. C., Wong, J., McCrossin, T., Cairns, M., & Weickert, C. S. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.110 · Cited by 609
Cytokine Alterations in Bipolar Disorder: A Meta-Analysis of 30 Studies
Modabbernia, A., Taslimi, S., Brietzke, E., & Ashrafi, M. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.01.007 · Cited by 596
Cytokines in bipolar disorder vs. healthy control subjects: A systematic review and meta-analysis
Munkholm, K., Braüner, J. V., Kessing, L. V., & Vinberg, M. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.05.018 · Cited by 402
Garay, P. A., Hsiao, E. Y., Patterson, P. H., & McAllister, A. K. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.07.008 · Cited by 366
Metadata
- Authors
- Kunz, M., Ceresér, K. M., Goi, P. D., Fries, G. R., Teixeira, A. L., Fernandes, B. S., Belmonte-de-Abreu, P. S., Kauer-Sant'Anna, M., Kapczinski, F., & Gama, C. S.
- Venue
- Revista Brasileira de Psiquiatria
- Publisher
- EDITORA SCIENTIFIC
- Published
- 2011-03-18
- Volume
- 33
- Issue
- 3
- Pages
- 268-274
- ISSN
- 1516-4446 (ISSN-L)
- 1809-452X
- OpenAlex
- W2159732985
- Cited by
- 190
- References
- 9
- FWCI
- 5.12
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Serum levels of IL-6, IL-10 and TNF-α in patients with bipolar disorder and schizophrenia: differences in pro- and anti-inflammatory balance. https://app.cochat.ai/papers/10.1590/s1516-44462011000300010
- The paper
- Kunz, M., Ceresér, K. M., Goi, P. D., Fries, G. R., Teixeira, A. L., Fernandes, B. S., Belmonte-de-Abreu, P. S., Kauer-Sant'Anna, M., Kapczinski, F., & Gama, C. S. (2011). Serum levels of IL-6, IL-10 and TNF-α in patients with bipolar disorder and schizophrenia: differences in pro- and anti-inflammatory balance. Revista Brasileira de Psiquiatria. https://doi.org/10.1590/s1516-44462011000300010
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.